Current status and perspectives in immunotherapy for metastatic melanoma

Metastatic melanoma was the first malignancy in which immune checkpoint inhibitors demonstrated their successful efficacy. Currently, the knowledge on the interaction between the immune system and malignant disease is steadily increasing and new drugs and therapeutic strategies are overlooking in th...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Marconcini, Riccardo, Spagnolo, Francesco, Stucci, Luigia Stefania, Ribero, Simone, Marra, Elena, Rosa, Francesco De, Picasso, Virginia, Di Guardo, Lorenza, Cimminiello, Carolina, Cavalieri, Stefano, Orgiano, Laura, Tanda, Enrica, Spano, Laura, Falcone, Alfredo, Queirolo, Paola
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2018
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5844761/
https://ncbi.nlm.nih.gov/pubmed/29552325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23746
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires